P438: INTRACELLULAR CITRATE LEVELS MODULATE ANTI-APOPTOTIC PROTEINS TO ENHANCE VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKEMIA STEM CELLS

P438: INTRACELLULAR CITRATE LEVELS MODULATE ANTI-APOPTOTIC PROTEINS TO ENHANCE VENETOCLAX SENSITIVITY IN ACUTE MYELOID LEUKEMIA STEM CELLS

Bibliographic Details
Main Authors:	Aykut Demir, Alireza Pouya, Maximilian Mönnig, Gernot Poschet, Carolin Andresen, Daniel Hübschmann, Nicola Zamboni, Carsten Müller-Tidow, Simon Raffel
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000968660.40006.cb

Similar Items

Comparison of extraction methods for intracellular metabolomics of human tissues
by: Carolin Andresen, et al.
Published: (2022-08-01)

Research progress of anti-apoptotic inhibitor venetoclax in treatment of myeloid leukemia
by: XIANG Caixia, HUANG Bintao, HAO Jian
Published: (2023-05-01)

Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
by: Cheng Zhou, et al.
Published: (2022-06-01)

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX.
by: Alexander Waclawiczek, et al.
Published: (2023-08-01)

Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
by: Mahesh Tambe, et al.
Published: (2024-10-01)

P470: SINGLE-CELL METABOLIC MULTIOMICS TO IDENTIFY VULNERABILITIES IN ACUTE MYELOID LEUKEMIA STEM CELLS
by: Magdalena Antes, et al.
Published: (2023-08-01)

Oridonin Synergistically Enhances the Pro-Apoptotic Effect of Venetoclax on Acute Myeloid Leukemia Cells by Inhibiting AKT Signaling
by: Lin Chen, et al.
Published: (2023-09-01)

P408: COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
by: Simon Renders, et al.
Published: (2023-08-01)

438 daftar pengambilan kedua UMP
by: Siti Nur Azwin, Zulkapri
Published: (2020)

JIB438 – Biological Safety (Keselamatan Biologi)
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2019)

Intracellular Antioxidant Activity of Biocompatible Citrate-Capped Palladium Nanozymes
by: Mauro Moglianetti, et al.
Published: (2020-01-01)

S. Hessen, Podstawy pedagogiki, Warszawa, ZAK 1997, s. 438.
by: Jan Niewęgłowski
Published: (1998-06-01)

438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
by: Nishank Jain, et al.
Published: (2023-04-01)

P323: UNCOVERING SUBCLONAL METABOLIC VULNERABILITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA AT SINGLE CELL RESOLUTION
by: Maximilian Mönnig, et al.
Published: (2023-08-01)

Izrael jako świadek Boga (Iz 43,8-13)
by: Wojciech Pikor
Published: (2015-11-01)

Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
by: Thomas E. Lew, et al.
Published: (2022-06-01)

Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent
by: Nickolas Steinauer, et al.
Published: (2024-03-01)

Intracellular Citrate/acetyl-CoA flux and endoplasmic reticulum acetylation: Connectivity is the answer
by: Gonzalo Fernandez-Fuente, et al.
Published: (2023-01-01)

Brain tumours in south Brazil a retrospective study of 438 cases
by: Luiz Fernando Bleggi Torres, et al.
Published: (1990-09-01)

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
by: Rabia Shahswar, et al.
Published: (2023-07-01)

Polymorphisms of Il-10 (-1082) and RANKL (-438) Genes and the Failure of Dental Implants
by: Rodrigo Ribeiro, et al.
Published: (2017-01-01)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
by: Daniele Mercatelli, et al.
Published: (2020-05-01)

Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines
by: Takeshi Onoue, et al.
Published: (2024-11-01)

Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
by: Gus O. Nwosu, et al.
Published: (2024-06-01)

Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate
by: Renshi Kawakatsu, et al.
Published: (2024-02-01)

Deep Metabolic Profiling Assessment of Tissue Extraction Protocols for Three Model Organisms
by: Hagen M. Gegner, et al.
Published: (2022-04-01)

Investigational venetoclax combination therapy in acute myeloid leukemia – a systematic review and meta-analysis
by: Shai Shimony, et al.
Published: (2022-08-01)

CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia
by: Lixiazi He, et al.
Published: (2022-03-01)

Analysis of the characteristics of HPV infection and its correlation with cervical cytology in 5 438 women
by: LI Yongjian, et al.
Published: (2024-12-01)

EP-438 - PERFIL SOCIODEMOGRÁFICO DA SÍFILIS CONGÊNITA EM 2023 NO RECIFE - PE
by: Plínio E.S. Gonçalves, et al.
Published: (2024-10-01)

Outdoor temperature and temperature maintenance associated with blood pressure in 438,811 Chinese adults
by: Shuojia Wang, et al.
Published: (2017-07-01)

Valproic Acid Enhances Venetoclax Efficacy in Targeting Acute Myeloid Leukemia
by: Renshi Kawakatsu, et al.
Published: (2025-01-01)

Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
by: Florian Ramdohr, et al.
Published: (2022-12-01)

Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma
by: Xinyi Jian, et al.
Published: (2024-06-01)

Clinical Study of Venetoclax with Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
by: CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia
Published: (2022-03-01)

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
by: Simona De Gregori, et al.
Published: (2023-06-01)

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
by: Ian M. Bouligny, et al.
Published: (2023-05-01)

Venetoclax: a primer
by: Andrew W. Roberts
Published: (2017-02-01)

Intracellular behavior of Nocardia seriolae and its apoptotic effect on RAW264.7 macrophages
by: Wenwen Liu, et al.
Published: (2023-02-01)

PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: Amer M Zeidan, et al.
Published: (2023-08-01)